Mark Lown

Dr. Mark Lown is an Associate Professor at the University of Southampton, affiliated with the Primary Care & Population Sciences department. His research focuses on infectious diseases, antimicrobial resistance, geriatrics, and clinical trial methodologies. He leads projects on antibiotic stewardship in care home settings, deprescribing interventions for older adults, and evaluation of antiviral treatments for high-risk populations. Notable contributions include the PANORAMIC trial assessing molnupiravir efficacy for COVID-19 and studies on urinary tract infection management in long-term care facilities.

His work spans interdisciplinary collaborations through groups like the Institute for Life Sciences and Primary Care Research Centre. Awards include the 2019 Healthcare Pioneer Award recognizing his impactful contributions to public health. Lown actively supervises PhD candidates in primary care and population sciences, contributing to both academic research and translational healthcare solutions.

• Key Projects: Screening for Atrial Fibrillation (SAFER), Antibiotics for LRTI in Older Adults, and Deprescribing Interventions
• Grants: Multiple NIHR and collaborative research grants

Labs/Teams: Active member of the Primary Care Research Centre and Institute for Life Sciences at the University of Southampton.